The Diabetes Pearl: Diabetes biobanking in The Netherlands

E van Riet; MT (Miranda) Schram; EJ Abbink; WM Admiraal; MW Dijk-Schaap; F Holleman; G Nijpels; Behiye Ozcan; H Pijl; NC Schaper; E.J.G. Sijbrands; B Silvius; CJ Tack; HW de Valk; BHR Wolffenbuttel; CDA Stehouwer; JM Dekker

doi:10.1186/1471-2458-12-949

The Diabetes Pearl: Diabetes biobanking in The Netherlands

E van Riet, MT (Miranda) Schram, EJ Abbink, WM Admiraal, MW Dijk-Schaap, F Holleman, G Nijpels, Behiye Ozcan, H Pijl, NC Schaper, E.J.G. Sijbrands, B Silvius, CJ Tack, HW de Valk, BHR Wolffenbuttel, CDA Stehouwer, JM Dekker

Research output: Contribution to journal › Article › Academic › peer-review

26 Citations (Scopus)

13 Downloads (Pure)

Abstract

Background: Type 2 diabetes is associated with considerable comorbidity and severe complications, which reduce quality of life of the patients and require high levels of healthcare. The Diabetes Pearl is a large cohort of patients diagnosed with type 2 diabetes, covering different geographical areas in the Netherlands. The aim of the study is to create a research infrastructure that will allow the study of risk factors, including biomarkers and genetic determinants for severe diabetes complications. Methods/design: Baseline examinations began November 2009 and will continue through 2012. By the end of 2012, it is expected that 7000 patients with type 2 diabetes will be included in the Diabetes Pearl cohort. To ensure quality of the data collected, standard operation procedures were developed and used in all 8 recruitment centers. From all patients who provide informed consent, the following information is collected: personal information, medication use, physical examination (antropometry, b Discussion: The Diabetes Pearl is large-scale cohort of type 2 diabetes patients in the Netherlands aiming to study risk factors, including biomarkers and genetic markers, for disease deterioration and the development of severe diabetes complications. As a result of the well-designed research design and the national coverage, the Diabetes Pearl data can be of great value to national and international researchers with an interest in diabetes related research.

Original language	Undefined/Unknown
Journal	BMC Public Health
Volume	12
DOIs	https://doi.org/10.1186/1471-2458-12-949
Publication status	Published - 2012

Research programs

EMC COEUR-09

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/1471-2458-12-949

REPUB_70900_OA.pdfFinal published version, 329 KB

http://hdl.handle.net/1765/70900

Cite this

van Riet, E., Schram, MT., Abbink, EJ., Admiraal, WM., Dijk-Schaap, MW., Holleman, F., Nijpels, G., Ozcan, B., Pijl, H., Schaper, NC., Sijbrands, E. J. G., Silvius, B., Tack, CJ., de Valk, HW., Wolffenbuttel, BHR., Stehouwer, CDA., & Dekker, JM. (2012). The Diabetes Pearl: Diabetes biobanking in The Netherlands. BMC Public Health, 12. https://doi.org/10.1186/1471-2458-12-949

@article{fe9b138708cd40909b44a5cffcc2a98d,

title = "The Diabetes Pearl: Diabetes biobanking in The Netherlands",

abstract = "Background: Type 2 diabetes is associated with considerable comorbidity and severe complications, which reduce quality of life of the patients and require high levels of healthcare. The Diabetes Pearl is a large cohort of patients diagnosed with type 2 diabetes, covering different geographical areas in the Netherlands. The aim of the study is to create a research infrastructure that will allow the study of risk factors, including biomarkers and genetic determinants for severe diabetes complications. Methods/design: Baseline examinations began November 2009 and will continue through 2012. By the end of 2012, it is expected that 7000 patients with type 2 diabetes will be included in the Diabetes Pearl cohort. To ensure quality of the data collected, standard operation procedures were developed and used in all 8 recruitment centers. From all patients who provide informed consent, the following information is collected: personal information, medication use, physical examination (antropometry, b Discussion: The Diabetes Pearl is large-scale cohort of type 2 diabetes patients in the Netherlands aiming to study risk factors, including biomarkers and genetic markers, for disease deterioration and the development of severe diabetes complications. As a result of the well-designed research design and the national coverage, the Diabetes Pearl data can be of great value to national and international researchers with an interest in diabetes related research.",

author = "{van Riet}, E and Schram, {MT (Miranda)} and EJ Abbink and WM Admiraal and MW Dijk-Schaap and F Holleman and G Nijpels and Behiye Ozcan and H Pijl and NC Schaper and E.J.G. Sijbrands and B Silvius and CJ Tack and {de Valk}, HW and BHR Wolffenbuttel and CDA Stehouwer and JM Dekker",

year = "2012",

doi = "10.1186/1471-2458-12-949",

language = "Undefined/Unknown",

volume = "12",

journal = "BMC Public Health",

issn = "1471-2458",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - The Diabetes Pearl: Diabetes biobanking in The Netherlands

AU - van Riet, E

AU - Schram, MT (Miranda)

AU - Abbink, EJ

AU - Admiraal, WM

AU - Dijk-Schaap, MW

AU - Holleman, F

AU - Nijpels, G

AU - Ozcan, Behiye

AU - Pijl, H

AU - Schaper, NC

AU - Sijbrands, E.J.G.

AU - Silvius, B

AU - Tack, CJ

AU - de Valk, HW

AU - Wolffenbuttel, BHR

AU - Stehouwer, CDA

AU - Dekker, JM

PY - 2012

Y1 - 2012

N2 - Background: Type 2 diabetes is associated with considerable comorbidity and severe complications, which reduce quality of life of the patients and require high levels of healthcare. The Diabetes Pearl is a large cohort of patients diagnosed with type 2 diabetes, covering different geographical areas in the Netherlands. The aim of the study is to create a research infrastructure that will allow the study of risk factors, including biomarkers and genetic determinants for severe diabetes complications. Methods/design: Baseline examinations began November 2009 and will continue through 2012. By the end of 2012, it is expected that 7000 patients with type 2 diabetes will be included in the Diabetes Pearl cohort. To ensure quality of the data collected, standard operation procedures were developed and used in all 8 recruitment centers. From all patients who provide informed consent, the following information is collected: personal information, medication use, physical examination (antropometry, b Discussion: The Diabetes Pearl is large-scale cohort of type 2 diabetes patients in the Netherlands aiming to study risk factors, including biomarkers and genetic markers, for disease deterioration and the development of severe diabetes complications. As a result of the well-designed research design and the national coverage, the Diabetes Pearl data can be of great value to national and international researchers with an interest in diabetes related research.

AB - Background: Type 2 diabetes is associated with considerable comorbidity and severe complications, which reduce quality of life of the patients and require high levels of healthcare. The Diabetes Pearl is a large cohort of patients diagnosed with type 2 diabetes, covering different geographical areas in the Netherlands. The aim of the study is to create a research infrastructure that will allow the study of risk factors, including biomarkers and genetic determinants for severe diabetes complications. Methods/design: Baseline examinations began November 2009 and will continue through 2012. By the end of 2012, it is expected that 7000 patients with type 2 diabetes will be included in the Diabetes Pearl cohort. To ensure quality of the data collected, standard operation procedures were developed and used in all 8 recruitment centers. From all patients who provide informed consent, the following information is collected: personal information, medication use, physical examination (antropometry, b Discussion: The Diabetes Pearl is large-scale cohort of type 2 diabetes patients in the Netherlands aiming to study risk factors, including biomarkers and genetic markers, for disease deterioration and the development of severe diabetes complications. As a result of the well-designed research design and the national coverage, the Diabetes Pearl data can be of great value to national and international researchers with an interest in diabetes related research.

U2 - 10.1186/1471-2458-12-949

DO - 10.1186/1471-2458-12-949

M3 - Article

C2 - 23130988

SN - 1471-2458

VL - 12

JO - BMC Public Health

JF - BMC Public Health

ER -